This week, there are 9 drugs in the patent and exclusivity list. They are: - AFT PHARMACEUTICALS US INC's COMBOGESIC, containing active ingredient ACETAMINOPHEN; IBUPROFEN - ACADIA PHARMACEUTICALS INC's NUPLAZID, containing active ingredient PIMAVANSERIN TARTRATE - NOVARTIS PHARMACEUTICALS CORP's TASIGNA, containing active ingredient NILOTINIB HYDROCHLORIDE - SECURA BIO INC's COPIKTRA, containing active ingredient DUVELISIB - UCB INC's FINTEPLA, containing active ingredient FENFLURAMINE HYDROCHLORIDE - PFIZER INC's VIZIMPRO, containing active ingredient DACOMITINIB - HARROW EYE LLC's IHEEZO, containing active ingredient CHLOROPROCAINE HYDROCHLORIDE - JAZZ PHARMACEUTICALS RESEARCH UK LTD's EPIDIOLEX, containing active ingredient CANNABIDIOL - INSMED INC's ARIKAYCE KIT, containing active ingredient AMIKACIN SULFATE Read More

This week, there are 9 drugs in the patent and exclusivity list. They are: - COLLEGIUM PHARMACEUTICAL INC's XTAMPZA ER, containing active ingredient OXYCODONE - SANTARUS INC's GLUMETZA, containing active ingredient METFORMIN HYDROCHLORIDE - INCYTE CORP's OPZELURA, containing active ingredient RUXOLITINIB PHOSPHATE - INCYTE CORP's JAKAFI, containing active ingredient RUXOLITINIB PHOSPHATE - FRESENIUS KABI USA LLC's SMOFLIPID 20%, containing active ingredient FISH OIL; MEDIUM CHAIN TRIGLYCERIDES; OLIVE OIL; SOYBEAN OIL - NOVARTIS PHARMACEUTICALS CORP's TASIGNA, containing active ingredient NILOTINIB HYDROCHLORIDE - NOVEN PHARMACEUTICALS INC's XELSTRYM, containing active ingredient DEXTROAMPHETAMINE - NOBELPHARMA CO LTD's HYFTOR, containing active ingredient SIROLIMUS - NOVARTIS PHARMACEUTICALS CORP's LOCAMETZ, containing active ingredient GALLIUM GA-68 GOZETOTIDE Read More